|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 311 - 320 of 441:
FDA Announces Audio Broadcasts on Emerging Drug Safety Information
The U.S. Food and Drug Administration (FDA) is alerting health care professionals and consumers to the availability of audio broadcasts that provide e...
FDA Approves Alpharma's KADIAN New 10mg Strength
Alpharma, a global specialty pharmaceutical company, today announced that it has been notified by the United States Food and Drug Administration("FDA"...
More Than 25 Healthcare Organizations Rely on Vernier Networks’ NAC Appliances to Bolster Security and HIPAA Compliance
Vernier Networks, supplier of award-winning network access control (NAC) appliances, has recently added more than 25 healthcare organizations to its g...
NMT Medical Receives FDA Approval for Modifications in Pivotal U.S. PFO/Stroke Trial
NMT Medical, an advanced medical technology company that designs, develops,manufactures and markets proprietary implant technologies that allow interv...
Oral Azacitidine Advances to Multi-Center, Multi-Cycle, Dose Escalation Study
Pharmion Corporation announced that the multi-center, open label Phase 1 clinical trial of single dose oral azacitidine in patients with MDS, AML and ...
Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin Injection to Treat Lung Cancer Brain Metastases
Pharmacyclics announced that the U.S. Food and Drug Administration (FDA) has filed the company's New Drug Application (NDA) for Xcytrin (motexafin gad...
Warnex successfully passes FDA inspection of its bioanalytical facilities
Warnex reported the favourable outcome from an inspection of its facilities performed by the U.S.Food and Drug Administration (FDA) and completed on A...
Worldwide Fish & Seafood, Inc. Enters Consent Decree with FDA
The U.S. Food and Drug Administration (FDA) announced that Worldwide Fish & Seafood, Inc., Minneapolis, MN, (doing business as Coastal Seafood) a sea...
Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
Abraxis BioScience, an integrated, global biopharmaceutical company, announced that it has received a tentative approval from the U.S. Food and Drug A...
Protalix BioTherapeutics Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Protalix BioTherapeutics announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate ... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |